Current status of the distal arteriovenous fistula as an adjunct to enhance prosthetic graft patency in lower limb revascularization

1995 ◽  
Vol 3 ◽  
pp. 118-118
Author(s):  
H DARDIK
1996 ◽  
Vol 24 (2) ◽  
pp. 240-248 ◽  
Author(s):  
Herbert Dardik ◽  
Fred Silvestri ◽  
Teresa Alasio ◽  
Silvia Berry ◽  
Mark Kahn ◽  
...  

1997 ◽  
Vol 5 ◽  
pp. S15
Author(s):  
F SOGARO ◽  
E GALEAZZI ◽  
D AMROCH ◽  
F BOCCHI ◽  
L GANASSIN

1991 ◽  
Vol 13 (5) ◽  
pp. 685-691 ◽  
Author(s):  
Kaj Andrew Johansen ◽  
Herbert Andrew Dardik ◽  
Silvia M. Berry ◽  
Alan M. Dardik ◽  
Fred M. Wolodiger ◽  
...  

1991 ◽  
Vol 13 (5) ◽  
pp. 685-691 ◽  
Author(s):  
Herbert Dardik ◽  
Silvia M. Berry ◽  
Alan Dardik ◽  
Fred Wolodiger ◽  
Joseph Pecoraro ◽  
...  

2020 ◽  
Vol 16 ◽  
Author(s):  
Ankit Awasthi ◽  
Sachin Kumar Singh ◽  
Bimlesh Kumar ◽  
Monica Gulati ◽  
Rajesh Kumar ◽  
...  

Background: Diabetic foot ulcer (DFU) is one of the leading complications of type-2 diabetes mellitus. It isassociated with neuropathy and peripheral arterial disease of the lower limb in patients with diabetes. Basically, there are four stages of wound healing namely hemostasis phase, inflammatory phase, proliferative phase and maturation phase. In case of DFU, all these stages are disturbed which lead to delay in healing and consequently to lower limb amputation. Traditionally the dosage forms like tablets, creams, ointments, gels and capsules have been used for the treatment of diabetic foot ulcer from many years. Introduction: In this review the global prevalence as well as etiopathogenesis related to diabetic foot ulcer has been discussed. Potential role of various synthetic and herbal drugs as well as their conventional dosage form for the effective management of diabetes foot ulcer has been highlighted. Methods: Structured search of bibliographic databases for previously published peer-reviewed research papers was explored and data was culminated in terms of various approaches that are used for the treatment of diabetic foot ulcer. Results: About 142 papers including both, research and review articles, were included in this review in order to produce a comprehensive as well as readily understandable article. A series of herbal and synthetic drugs have been discussed along with their current status of treatment in terms of dose and mechanism of action. Conclusion: DFU has become one of the most common complications in patients having more than ten years of diabetes. Hence, understanding the root cause and its successful treatment is a big challenge because it depends upon multiple factors such as judicious selection of drug as well as proper control of blood sugar level. Most of the drugs that have been used so far either belong to the category of antibiotics, antihyperglycaemics or, they have been repositioned. Moreover, in clinical practice, much focus has been given towards dressings that have been used to cover the ulcer. The complete treatment of DFU is still a farfetched dream to be achieved and it is expected that a combination therapy of herbal and synthetic drug with multiple treatment pathway could be able to overcome the disease.


Perfusion ◽  
2001 ◽  
Vol 16 (5) ◽  
pp. 417-428 ◽  
Author(s):  
Li-Chien Hsu

Heparin-coated circuits have been subjected to vigorous testing, both experimentally and clinically, for the past decade. When the functions of heparin are preserved on the surface, the heparinized surface plays multiple roles in attenuating the systemic inflammatory response. These include the ability to attenuate contact activation, coagulation activation, complement activation and, directly or indirectly, platelet and leukocyte activation. The heparinized surface also renders the cardiopulmonary bypass (CPB) circuits hydrophilic and protein resistant and augments lipoprotein binding. The multifunctional nature of the heparinized surface contributes to the overall biocompatibility of the surface. Clinically, heparin-coated circuits become most effective in reducing systemic inflammatory response and in improving morbidity, mortality, and other patient outcome related parameters when material-independent blood activation is controlled or minimized through a global biocompatibility strategy. Techniques involved in the global biocompatibility strategy are readily available and are being effectively and safely practiced at several centers. With the global biocompatibility strategy, outstanding and reproducible results have been routinely achieved with conventional CPB techniques. Alternative revascularization procedures should equal or surpass conventional CPB, using best clinically proven strategies with respect to patient outcome and long-term graft patency.


2017 ◽  
Vol 8 (1) ◽  
pp. 3
Author(s):  
Vimlesh Soni ◽  
Pankaj C Vaidya ◽  
Jitendra Kumar SSahu ◽  
Mukesh Yadav ◽  
Pratibha Singhi

Concurrent spinal dural arteriovenous fistula (AVF) and cecal arteriovenous malformation (AVM) are very rare. A 6-year old boy presented with lower limb paresis after trauma. On imaging work-up spinal dural AVF was found. It was managed with endovascular glue embolization. After two years, the boy presented with severe anemia and occult gastrointestinal tract (GIT) bleed. Cecal AVM was diagnosed and managed with embolization.


2016 ◽  
Vol 34 ◽  
pp. 143-144
Author(s):  
Fumitaka Yanase ◽  
Masato Kato ◽  
Ryutaro Matsumoto ◽  
Tetsu Horaguchi ◽  
Hiroyuki Kinoshita

Sign in / Sign up

Export Citation Format

Share Document